Scarica l'app Stockscreener
5.31
6.84%
-0.39
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways - Yahoo Finance
Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? - Insider Monkey
Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN
Where are the Opportunities in (DNA) - news.stocktradersdaily.com
Largest borrow rate increases among liquid names - TipRanks
Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing - MSN
(DNA) Technical Pivots with Risk Controls - Stock Traders Daily
After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - Yahoo Finance
SBI Securities Co. Ltd. Acquires Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why - MSN
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consort - GuruFocus.com
Ginkgo Bioworks (DNA) Insider Trading Activity 2025 - MarketBeat
Ginkgo Bioworks CFO sells shares worth $6,102 - Investing.com India
Ginkgo Bioworks CFO sells shares worth $6,102 By Investing.com - Investing.com Australia
Ginkgo Bioworks executive sells shares for over $3k - Investing.com
Y Intercept Hong Kong Ltd Purchases New Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
(DNA) Pivots Trading Plans and Risk Controls - Stock Traders Daily
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022DNA - ACCESS Newswire
Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.
Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire
Top 5 Synthetic Biology Public Companies (March 2025) - Securities.io
These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - Simply Wall St
Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap DownHere's What Happened - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Posts Quarterly Earnings Results, Misses Expectations By $0.37 EPS - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Posts Earnings Results - MarketBeat
DNA; SRNG Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Deadline: January 18, 2022 - ACCESS Newswire
Ginkgo Bioworks Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
Ginkgo Bioworks Shrinks Office and Lab Footprint in Boston, Cambridge - Connect CRE
Ginkgo Bioworks: Revenue Struggles Continue - Seeking Alpha
2025 Is Make Or Break For Ginkgo Bioworks (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Holdings Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Ginkgo Bioworks: Key Takeaways from Q4 and Full-Year 2024 Earnings Report - HPBL
Cautious Outlook on Ginkgo Bioworks: Sell Rating Amid Financial and Strategic Concerns - TipRanks
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Holdings Inc (DNA) Q4 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q4 Loss, Misses Revenue Estimates - MSN
Ginkgo Bioworks Reports Improved Q4 2024 Results - TipRanks
Ginkgo subleases part of HQ, looks to address $65M of excess space - The Business Journals
Ginkgo Bioworks Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financ - GuruFocus.com
Ginkgo Bioworks Holdings, Inc. SEC 10-K Report - TradingView
Ginkgo Bioworks Holdings, Inc. Q4 Loss Narrows - Nasdaq
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results - Kilgore News Herald
Ginkgo Bioworks (DNA) to Release Quarterly Earnings on Tuesday - MarketBeat
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 – DNA - ACCESS Newswire
Ginkgo Bioworks (NYSE:DNA) Trading Down 6.3%What's Next? - MarketBeat
2.65%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):